Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics

J Endocrinol Invest. 2020 Sep;43(9):1197-1204. doi: 10.1007/s40618-020-01198-5. Epub 2020 Feb 15.

Abstract

Background: Adrenal lipid-poor adenomas (LPA) are defined by high unenhanced density (≥ 10 HU), and absolute and relative contrast medium washout > 60% and > 40%, respectively, at computerized tomography (CT). To date, no thorough histopathological characterization has been performed in those frequent lesions (one-third of adrenal adenomas). Our aim was to analyze the histopathological characteristics of adrenal LPA.

Methods: Patients with LPA (n = 57) were selected among consecutive subjects referred for an adrenal incidentaloma or ACTH-independent Cushing syndrome. FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) was performed in 37 patients. In patients treated by adrenalectomy (n = 17), Weiss score and Lin-Weiss-Bisceglia score (in tumors composed entirely or predominantly of oncocytes) were calculated.

Results: Radiological parameters did not differ among patients with ACTH-independent Cushing syndrome (n = 6) and those with adrenal incidentalomas associated with primary aldosteronism (n = 2), autonomous cortisol secretion (n = 14), or non-functioning (n = 35). Patients treated by adrenalectomy had larger tumors (28.9 ± 11.2 vs 17.3 ± 8.4 mm, P < 0.001), higher CT unenhanced density (29.1 ± 11.0 vs 23.1 ± 9.0 HU, P = 0.043), and FDG-PET adrenal uptake (9.0 ± 6.4 vs 4.4 ± 2.3 SUV, P = 0.003) than non-operated ones. Oncocytic features > 75% of the tumor were detected in 12/17 cases (70.6%). Five of those showed borderline-malignant histopathological characteristics by Lin-Weiss-Bisceglia score. Among remaining non-oncocytic tumors, 1/5 had a Weiss score ≥ 3. Overall, 6/17 tumors (35.3%) had borderline-malignant potential. Radiological parameters were similar between patients with benign and borderline-malignant tumors.

Conclusions: Adrenal LPA are a heterogeneous group of tumors, mostly composed of oncocytomas. Up to 1/3 of those tumors may have a borderline-malignant potential at histopathology.

Keywords: Adrenal oncocytoma; Adrenal tumor; Borderline-malignant; Lipid-poor adenoma.

MeSH terms

  • ACTH Syndrome, Ectopic / diagnosis
  • ACTH Syndrome, Ectopic / etiology
  • ACTH Syndrome, Ectopic / metabolism
  • ACTH Syndrome, Ectopic / pathology
  • Adenoma / diagnosis*
  • Adenoma / metabolism
  • Adenoma / pathology
  • Adrenal Gland Neoplasms / diagnosis*
  • Adrenal Gland Neoplasms / metabolism
  • Adrenal Gland Neoplasms / pathology
  • Adrenocorticotropic Hormone / metabolism
  • Adult
  • Aged
  • Biopsy
  • Cohort Studies
  • Cushing Syndrome / diagnosis
  • Cushing Syndrome / etiology
  • Cushing Syndrome / metabolism
  • Cushing Syndrome / pathology
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Italy
  • Lipid Metabolism
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Tomography, X-Ray Computed

Substances

  • Fluorodeoxyglucose F18
  • Adrenocorticotropic Hormone

Supplementary concepts

  • Adrenal incidentaloma